Cervical cancer is found through screening tests, not symptoms. In most cases, the disease develops slowly over years without any noticeable signs, which is why routine screening catches it early and often before it becomes cancer at all. If you’re wondering whether you might have cervical cancer, the answer depends on whether you’ve been keeping up with screening, whether you have symptoms, or both.
Screening Tests That Detect Cervical Cancer
Two main screening tests exist: the HPV test and the Pap smear. They serve different but overlapping purposes. The HPV test checks for the presence of high-risk strains of human papillomavirus, the virus responsible for virtually all cervical cancers. Two strains in particular, HPV 16 and HPV 18, cause about 70% of cases worldwide. The Pap smear (also called a Pap test) collects cells from your cervix and examines them under a microscope for abnormalities.
The HPV test is better at catching precancerous changes. In pooled research data, HPV testing detected precancerous lesions with about 93% sensitivity, compared to 66% for a traditional Pap smear and 76% for a liquid-based version. That said, the Pap smear is more specific, meaning it produces fewer false alarms. Many providers use both tests together (called co-testing) to get the most complete picture.
Your screening schedule depends on your age:
- Ages 21 to 29: Pap test every three years if results are normal.
- Ages 30 to 65: Three options. An HPV test alone every five years, an HPV test combined with a Pap test every five years, or a Pap test alone every three years.
If you’re over 65 and have had consistently normal results, screening generally stops. If you’re under 21, screening isn’t recommended regardless of sexual activity, because cervical changes at that age almost always resolve on their own.
What Abnormal Results Actually Mean
An abnormal screening result does not mean you have cancer. Most abnormal results point to early cell changes that may never progress. Results are reported using a standardized system, and the most common categories you might see on your report include:
- ASC-US: Atypical squamous cells of undetermined significance. This is the mildest abnormality. It means some cells look slightly unusual but not clearly precancerous. Your provider will typically follow up with an HPV test if one wasn’t already done.
- LSIL: Low-grade changes, often caused by an HPV infection. These correspond to mild cell changes that frequently clear up without treatment, especially in younger women.
- HSIL: High-grade changes that represent moderate to severe precancerous cells. This result requires further evaluation because these changes are more likely to progress to cancer if left untreated.
False negatives do happen. Research has found that when Pap slides are re-examined after a missed diagnosis, over 50% of the time the abnormal cells were actually present on the original slide but were misinterpreted as normal. This is one reason why keeping up with regular screening matters. A single normal result isn’t a lifetime guarantee, but repeated normal results over time are very reassuring.
Self-Collection Options
In May 2024, the FDA approved expanded use of two HPV tests to allow self-collected vaginal swabs. The catch: you still do this in a healthcare setting, not at home. It’s designed for people who find a traditional pelvic exam difficult or who have avoided screening for that reason. You collect the sample yourself using a swab, and the lab runs the same HPV test that would be used on a clinician-collected sample. If you’ve been putting off screening because of discomfort with pelvic exams, ask your provider whether self-collection is available.
Symptoms That Warrant Evaluation
Early cervical cancer rarely causes symptoms. By the time symptoms appear, the disease has usually progressed beyond its earliest stages. The signs to pay attention to include vaginal bleeding after sex, bleeding between periods, periods that are heavier or longer than usual, and any vaginal bleeding after menopause. These symptoms have many possible causes besides cancer, but they all deserve a visit to your provider, especially if they’re new or persistent.
What Happens After an Abnormal Result
If screening turns up something concerning, the next step is usually a colposcopy. This is a 10- to 20-minute office procedure where your provider uses a magnifying instrument (positioned a few inches away, not inserted) to get a close look at your cervix. You’ll be in the same position as a regular pelvic exam. A vinegar solution is applied to the cervix, which causes abnormal areas to turn white, making them visible.
If your provider spots suspicious-looking tissue during the colposcopy, they’ll take a small tissue sample called a biopsy. This involves a quick snip with a small instrument. You may feel a pinch or cramping. Multiple samples can be taken if there are several areas of concern. The tissue goes to a lab, and pathologists examine it to determine whether the cells are precancerous, cancerous, or benign.
When More Tissue Is Needed
Sometimes a small punch biopsy doesn’t provide enough information, or the abnormal cells are located higher in the cervical canal where they can’t be easily seen. In those cases, your provider may recommend one of two procedures to remove a larger piece of tissue. A LEEP uses a thin, electrically charged wire loop to shave off a section of abnormal tissue. It’s typically done in the office with local anesthesia and has a relatively quick recovery. A cone biopsy (also called conization) uses a surgical knife to remove a larger, cone-shaped section of the cervix. It’s performed under general anesthesia, takes longer to recover from, and carries more risk than LEEP. Both procedures serve as diagnosis and treatment at the same time, since they remove the abnormal tissue entirely in many cases.
If Cancer Is Confirmed
When a biopsy confirms cervical cancer, imaging tests help determine how far the disease has spread. Pelvic MRI is commonly used to assess the size of the tumor and whether it has grown into nearby tissues. For more advanced cases, or when lymph nodes look suspicious on initial imaging, a PET-CT or contrast-enhanced CT scan of the chest, abdomen, and pelvis checks for spread beyond the pelvic area. The results of these scans determine the stage of the cancer, which directly shapes the treatment plan.
The staging process can feel overwhelming, but it’s designed to give your medical team the clearest possible picture of what they’re dealing with. Early-stage cervical cancer caught through screening has a very different outlook and treatment path than cancer found after symptoms develop, which is the strongest argument for not skipping your routine screening appointments.
Who Faces Higher Risk
Persistent infection with high-risk HPV is the primary cause of cervical cancer, but not everyone with HPV develops it. Your risk is higher if you smoke, have a weakened immune system (including from HIV), have had multiple full-term pregnancies, or started having sex at a young age. Long-term use of oral contraceptives (five years or more) has also been linked to a modest increase in risk, though that risk declines after stopping.
HPV vaccination dramatically reduces the risk of infection with the strains most likely to cause cancer. If you were vaccinated, your risk is substantially lower, but screening is still recommended because the vaccine doesn’t cover every high-risk strain. If you weren’t vaccinated and you’re under 26 (or in some cases up to 45), it’s worth discussing catch-up vaccination with your provider.